These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 25700363)
1. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363 [TBL] [Abstract][Full Text] [Related]
2. Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa. Ngwewondo A; Wang M; Manfo FPT; Samje M; Ganin's JN; Ndi E; Andersen RJ; Cho-Ngwa F PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006565. PubMed ID: 29897908 [TBL] [Abstract][Full Text] [Related]
3. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis. Halliday A; Guimaraes AF; Tyrer HE; Metuge HM; Patrick CN; Arnaud KO; Kwenti TD; Forsbrook G; Steven A; Cook D; Enyong P; Wanji S; Taylor MJ; Turner JD Parasit Vectors; 2014 Oct; 7():472. PubMed ID: 25338621 [TBL] [Abstract][Full Text] [Related]
4. Flubendazole as a macrofilaricide: History and background. Geary TG; Mackenzie CD; Silber SA PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006436. PubMed ID: 30650160 [TBL] [Abstract][Full Text] [Related]
5. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054 [TBL] [Abstract][Full Text] [Related]
6. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns. Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363 [TBL] [Abstract][Full Text] [Related]
7. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi. Wanji S; Amvongo-Adjia N; Njouendou AJ; Kengne-Ouafo JA; Ndongmo WP; Fombad FF; Koudou B; Enyong PA; Bockarie M Parasit Vectors; 2016 May; 9():267. PubMed ID: 27151313 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery. Ayiseh RB; Mbah GE; Monya E; Ndi EM; Sakanari J; Lustigman S; Cho-Ngwa F PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011135. PubMed ID: 36827447 [TBL] [Abstract][Full Text] [Related]
9. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations. Shenoy RK; Dalia S; John A; Suma TK; Kumaraswami V Ann Trop Med Parasitol; 1999 Sep; 93(6):643-51. PubMed ID: 10707109 [TBL] [Abstract][Full Text] [Related]
10. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Mackenzie CD; Geary TG Expert Rev Anti Infect Ther; 2011 May; 9(5):497-501. PubMed ID: 21609260 [No Abstract] [Full Text] [Related]
11. Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models. Sjoberg HT; Pionnier N; Aljayyoussi G; Metuge HM; Njouendou AJ; Chunda VC; Fombad FF; Tayong DB; Gandjui NVT; Akumtoh DN; Chounna PWN; Ndzeshang BL; Lachaud S; Tekle F; Quirynen L; Engelen M; Baeten B; Steven A; Ward SA; Taylor MJ; Wanji S; Turner JD PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006356. PubMed ID: 30650071 [TBL] [Abstract][Full Text] [Related]
12. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens. Mbah GE; Ayiseh RB; Cho-Ngwa F BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037 [TBL] [Abstract][Full Text] [Related]
14. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro. Hübner MP; Martin C; Specht S; Koschel M; Dubben B; Frohberger SJ; Ehrens A; Fendler M; Struever D; Mitre E; Vallarino-Lhermitte N; Gokool S; Lustigman S; Schneider M; Townson S; Hoerauf A; Scandale I PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008427. PubMed ID: 32628671 [TBL] [Abstract][Full Text] [Related]
15. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958 [TBL] [Abstract][Full Text] [Related]
16. The role of albendazole in programmes to eliminate lymphatic filariasis. Ottesen EA; Ismail MM; Horton J Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168 [TBL] [Abstract][Full Text] [Related]
17. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149 [TBL] [Abstract][Full Text] [Related]
18. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria. Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086 [TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis. Opoku NO; Doe F; Dubben B; Fetcho N; Fischer K; Fischer PU; Gordor S; Goss CW; Gyasi ME; Hoerauf A; Hong AR; Kanza E; King CL; Laryea R; Lew D; Seidu MA; Weil GJ PLoS Negl Trop Dis; 2023 May; 17(5):e0011365. PubMed ID: 37205721 [TBL] [Abstract][Full Text] [Related]